Nov 2026· Theoretical and Natural Science· 0 citations
TL;DR
Experimental results demonstrated that the developed sensing system exhibited outstanding specificity, effectively discriminating against single-base mismatches and minimizing nonspecific interference, and achieved an ultrahigh detection sensitivity down to 1.31 fM.
Abstract
Rapid and accurate nucleic acid detection plays a pivotal role in pathogen screening, clinical diagnosis, and molecular biology research. However, conventional polymerase chain reaction (PCR)-based detection methods suffer from inherent limitations, making them difficult to fully meet the practical requirements of point-of-care testing (POCT). The CRISPR-Cas12a system has emerged as a promising platform for rapid next-generation nucleic acid detection, leveraging its exceptional target recognition specificity and collateral trans-cleavage activity against single-stranded DNA (ssDNA) reporters upon target activation, coupled with the high sensitivity and facile readout of fluorescence-based sensing strategies. This study aimed to develop an efficient, convenient, and highly sensitive CRISPR-Cas12a-coupled fluorescence sensing platform for rapid nucleic acid detection. By optimizing the ratio of Cas12a protein to specific crRNA, incorporating isothermal pre-amplification, and introducing a nanomaterial-based signal enhancement strategy, the proposed system enabled rapid target nucleic acid responses under a mild temperature condition of 37°C. Experimental results demonstrated that the developed sensing system exhibited outstanding specificity, effectively discriminating against single-base mismatches and minimizing nonspecific interference. Furthermore, the platform achieved an ultrahigh detection sensitivity down to 1.31 fM, while reducing the total assay time to less than 45 min.
CATNAP (Cas trans -nuclease detection of amplified products), a method that integrates isothermal linear DNA amplification with Cas12a detection in a single reaction, bridges the sensitivity gap in CRISPR diagnostics while maintaining simplicity, making accurate disease detection more accessible in resource-limited setti...
S. Sinan, Remy M. Kooistra, Karunya Rajaraman et al.· 0 citations
Measurement of protein biomarkers with high accuracy is critical for disease diagnostics and prognostic monitoring. However, conventional analytical platforms for protein detection suffer from insufficient sensitivity for low-abundance targets and require time-consuming, multi-step workflows. The CRISPR-Cas system is e...
Shao-Kun Dong, Shuai Zhao, Jin-Qi Deng et al.· Small Methods· 0 citations
Rapid, portable detection of multiple nucleic acid targets is essential for infectious disease surveillance and precision oncology. CRISPR-based diagnostics have set a high bar for sensitivity and single-base specificity, yet their reliance on collateral nuclease activity complicates multiplexing, integration with ampl...
Padric M. Garden, Yu-Dan Li, V. Murugan et al.· ACS Sensors· 0 citations
Rapid and sensitive detection of Staphylococcus aureus (S. aureus) is critical for food safety and public health. Herein, this work developed an ABC (aptamer-B-PER-CRISPR) cascade detection platform, where B-PER stands for bidirectional primer exchange reaction, that integrates aptamer-mediated target recognition, B-PE...
Jia-Lin Jiang, Yuan Peng, Wen-Jie Ma et al.· Analytical Methods· 0 citations
CRISPR/Cas12a-assisted nucleic acid assays have shown great potential for rapid pathogen detection. However, their implementation in lateral flow assays remains constrained by strict protospacer adjacent motif (PAM) requirements and low-contrast, signal-off readouts. To effectively address these limitations, we prese...
CRISPR/Cas12a-based diagnostics achieved attomolar sensitivity for nucleic acid detection, yet their extension to small-molecule targets remains constrained by the need for solution-phase aptasensor–CRISPR coupling and laboratory infrastructure incompatible with resource-limited settings. Here we report a Paper-integra...
Anindita Sen, Douglas James Bock, Tegan Foster et al.· RSC Advances· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.